Archive for June, 2008

Childhood Cancer Survivors Remain at Risk

Monday, June 23rd, 2008

More: continued here

Study finds weight-loss surgery cuts cancer risk

Monday, June 23rd, 2008

Morbidly obese patients who undergo weight-loss surgery greatlyreduce their risk of cancer, according to a study providing freshevidence of health benefits from these increasingly commonoperations.

More: continued here

Facility Characteristics Influence Mammography Accuracy

Monday, June 23rd, 2008

Where screening is performed as important as who interpretsresults, study finds

More: continued here

Cancer Survivors Stuck in Limbo

Monday, June 23rd, 2008

More: continued here

Avastin slows progress of breast cancer in trial

Monday, June 23rd, 2008

The addition of Genentech Inc’s cancer drug Avastin to chemotherapyslows the progress of breast cancer at two different doses,according to results of a large international trial released onSaturday.

More: continued here

Primary Tumors Fuel Growth of Cancer Cells

Monday, June 23rd, 2008

Finding suggests interception of this signal may thwart metastases,study says

More: continued here

Bone drug helped stave off breast cancer

Monday, June 23rd, 2008

A drug used to strengthen the bones of women with breast cancerhelped cut the risk of the cancer returning by 36 percent, Europeanresearchers said on Saturday,

More: continued here

Bone Drug Lowers Risk of Breast Cancer Recurrence

Monday, June 23rd, 2008

Zometa, used to treat osteoporosis, showed no unanticipated sideeffects, researchers report

More: continued here

Roche breast cancer pill fails to help older women

Monday, June 23rd, 2008

Swiss drugmaker Roche Holding AG’s oral chemotherapy drug Xeloda,or capecitabine, proved inferior to standard chemotherapy intreating older women with early stage breast cancer, a studyreleased on Saturday at a major meeting of oncology specialistsfound.

More: continued here

Avastin Added to Chemo Helps Women With Advanced Breast Cancer

Monday, June 23rd, 2008

Anti-angiogenesis drug prolonged progression-free survival, studyfinds

More: continued here